Fasudil, a clinically safe ROCK inhibitor, decreases disease burden in a Cbl/Cbl-b deficiency-driven murine model of myeloproliferative disorders.
about
Fasudil, a clinically safe ROCK inhibitor, decreases disease burden in a Cbl/Cbl-b deficiency-driven murine model of myeloproliferative disorders.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Fasudil, a clinically safe ROC ...... myeloproliferative disorders.
@en
type
label
Fasudil, a clinically safe ROC ...... myeloproliferative disorders.
@en
prefLabel
Fasudil, a clinically safe ROC ...... myeloproliferative disorders.
@en
P2093
P2860
P1433
P1476
Fasudil, a clinically safe ROC ...... myeloproliferative disorders.
@en
P2093
Basem M William
Hamid Band
Matthew A Storck
Scott Nadeau
Vimla Band
P2860
P304
P356
10.1179/1607845415Y.0000000031
P577
2015-07-15T00:00:00Z